Huiting Su
- Immunology top 10%
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 2
-
- RNA modifications and cancer 4
-
- Virus-based gene therapy research 2
-
- Tuberculosis Research and Epidemiology 2
-
- Hybrid Renewable Energy Systems 2
-
- Mycobacterium research and diagnosis 2
-
- Pharmacological Effects of Natural Compounds 2
- Co-authors
- Yong ZhaoNing NaXiaodong ZhangYang ZhaoLiping ZhangXiaofei ShenJunfeng DuJu Cao
- Cited by
- ImmunologyOncologyCancer Research
In The Last Decade
Huiting Su
22 papers receiving 586 citations
Peers
Comparison fields: 5 of 88
- Immunology 240
- Oncology 122
- Cancer Research 58
- Transplantation 9
- Molecular Biology 195
Countries citing papers authored by Huiting Su
This map shows the geographic impact of Huiting Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiting Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiting Su more than expected).
Fields of papers citing papers by Huiting Su
This network shows the impact of papers produced by Huiting Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiting Su. The network helps show where Huiting Su may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huiting Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 19 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 2 | |
| 12 | 2020 | 51 | |
| 13 | 2020 | 28 | |
| 14 | 2017 | 12 | |
| 15 | 2017 | 45 | |
| 16 | 2017 | 80 | |
| 17 | 2016 | 33 | |
| 18 | 2016 | 7 | |
| 19 | 2016 | 195 | |
| 20 | 2016 | 1 |
About Huiting Su
Huiting Su is a scholar working on Microbiology, Energy Engineering and Power Technology, Immunology, Geriatrics and Gerontology and Pharmacology, having authored 24 papers that have together received 589 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Immune Cell Function and Interaction (3 papers), Virus-based gene therapy research (2 papers), Tuberculosis Research and Epidemiology (2 papers), Hybrid Renewable Energy Systems (2 papers), Mycobacterium research and diagnosis (2 papers), Immunotherapy and Immune Responses (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Immunology (240 citations), Oncology (122 citations), Cancer Research (58 citations), Transplantation (9 citations) and Molecular Biology (195 citations). Huiting Su has collaborated with scholars based in China, Taiwan and Russia. Frequent co-authors include Yong Zhao, Ning Na, Xiaodong Zhang, Yang Zhao, Liping Zhang, Xiaofei Shen, Junfeng Du, Xiaodong Zhang, Ju Cao and Chao‐Yung Wang. Their work appears in journals such as Inflammation Research, Scientific Reports, Journal of Visualized Experiments, iScience and Virology Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.